Citi upgraded Bellicum Pharmaceuticals (NASDAQ: BLCM) from Neutral to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Upgrades

Jefferies Raises Price Target on Bellicum Pharma (BLCM) to $22; Reiterates Buy August 9, 2016 9:50 AM